Swedish polymer products group Nolato (LSE:0OA9) reported higher third-quarter sales and higher operating cash flow, although its EBITA margin narrowed to 10.2% as input costs rose and automotive demand weakened.
What was announced
Nolato AB published its interim report for the third quarter of 2026 on 29 October under a headline highlighting strategic acquisitions and solid organic growth for Medical Solutions. The Nasdaq Stockholm-listed maker of plastic, silicone and TPE products reported net sales of SEK 2,500 million for the quarter, compared with SEK 2,342 million a year earlier. That is a reported increase of about 7%, with organic growth, adjusted for currency and acquisitions, of 3%.
Profitability moved the other way. Operating profit (EBITA) fell to SEK 254 million from SEK 281 million, and the EBITA margin narrowed to 10.2% from 12.0%. Profit after tax was SEK 172 million against SEK 215 million, and basic and diluted earnings per share came to SEK 0.64, down from SEK 0.80. Operating cash flow was a bright spot, rising to SEK 332 million from SEK 301 million.
The numbers
For the first nine months of 2026, net sales were SEK 7,311 million (SEK 7,190 million), with organic growth of 3%. EBITA for the period was SEK 761 million (SEK 829 million), giving a margin of 10.4% (11.5%). Profit after tax was SEK 522 million (SEK 626 million) and earnings per share were SEK 1.94 (SEK 2.32). Operating cash flow for the nine months rose to SEK 844 million from SEK 752 million.
The quarter included a one-off charge of SEK 8 million for acquisition costs, while the third quarter of 2025 had benefited from a net one-off gain of SEK 7 million linked to an insurance claim. Chief executive Anders Björklund said higher prices for input goods were a temporary headwind and partly explained the margin decline. He described the business environment as "persistently challenging". Net debt to EBITDA stood at 1.0 times at the end of the quarter, which the company said provides financial flexibility.
Business areas
Medical Solutions was the main growth engine. Net sales rose to SEK 1,469 million from SEK 1,311 million, equivalent to 9% organic growth and about 12% on a reported basis. EBITA increased to SEK 166 million from SEK 159 million, although the margin slipped to 11.3% from 12.1%. Growth was broad across most market areas, led by drug delivery on higher volumes of newer products, while in vitro diagnostics also grew. Expansion investments at several existing facilities are proceeding according to plan.
Engineered Solutions had a tougher quarter. Net sales were broadly flat at SEK 1,040 million (SEK 1,035 million), representing an organic decline of 3%, and EBITA fell to SEK 112 million from SEK 120 million, a margin of 10.8% (11.6%). Consumer electronics volumes were stable, but automotive declined sharply on lower customer demand and model changeovers. Hygiene was affected by customer inventory adjustments, although volumes stabilised sequentially. Within the business area's commentary, Materials saw sharply higher shipment volumes and steady profitability, with growth in all customer segments, notably data centres and satellites, aerospace and defence, and automotive.
Acquisitions and what to watch next
During the quarter Nolato completed the acquisitions of Unitron, a Dutch company, and part of Qualtech, an Irish company. Both were consolidated for one month, from September. Together they add approximately SEK 600 million in annual sales at an EBITA margin in line with the group, with most of their sales falling within drug delivery. The company said the deals strengthen its capabilities in electronics-intensive medical technology, systems integration and complete systems, including electronics and development expertise.
The report contains no explicit financial guidance. Points to watch include the first full-quarter contribution from Unitron and Qualtech, whether input cost pressure eases as management expects, the trajectory of automotive and hygiene demand in Engineered Solutions, and progress on the Medical Solutions capacity expansions.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...